Story

Electrovaya Shares Soar 50% After Securing Commercial Agreement with Amazon

ENTHMSVIIDZHZH-TWJAKOHI
Jul 15, 20261 min read
Electrovaya Shares Soar 50% After Securing Commercial Agreement with Amazon

Summary

The lithium-ion battery manufacturer announced a deal that includes warrants for Amazon to purchase shares, contingent on future product sales, sending Electrovaya's stock price sharply higher.

Text size
Background

Shares of Electrovaya Inc. (NASDAQ: ELVA) surged as much as 50% on Wednesday after the company announced a significant commercial agreement and warrant transaction with e-commerce giant Amazon.

Details of the Agreement

Under the terms of the deal, Electrovaya will issue warrants to Amazon for the purchase of up to 13,880,345 of its common shares. The company stated that a portion of these warrants will vest immediately upon the execution of the agreement.

The full vesting of the warrants is contingent on Amazon making cumulative purchases of $280 million from Electrovaya in the future. The exercise price for the warrants will be based on the 5-day volume-weighted average trading price of Electrovaya's stock immediately preceding the agreement date.

Strategic Rationale and Market Impact

The agreement is expected to support the continued deployment of Electrovaya's Infinity Battery Technology in Amazon's material handling operations. The companies also noted the potential for expanded engagement in areas like robotics and energy storage.

Sample IUX Markets – In-articleAd

"Electrovaya’s Infinity Battery Technology has demonstrated real performance in demanding material handling environments, and this agreement with Amazon reflects our confidence in the opportunity ahead," said Raj DasGupta, CEO of Electrovaya. He added that the company looks forward to building on this foundation for other industrial applications.

Technology and Outlook

Electrovaya's Infinity lithium-ion technology is designed for applications where safety and longevity are critical. The company highlights its strong field safety record, lower total cost of ownership, and a reduced environmental footprint compared to conventional lithium-ion batteries.

Systems currently in development aim to combine this technology with high-power architectures for use in data centers and other industrial and logistics applications, focusing on enhanced safety, cycle life, and rapid charging capabilities.

Read next

More on Stocks
Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Stocks

Shenzhen-Listed Jingxin Pharmaceutical Refiles for Hong Kong IPO

Sep 20, 2026

Zhejiang Jingxin Pharmaceutical Co., Ltd. (002020.SZ) has resubmitted its application for a main board listing on the Hong Kong Stock Exchange, aiming to secure a dual listing to access international capital. The company specializes in drugs for central nervous system and cardiovascular diseases.

Back to latest news

LATEST